Investment Risk

Business

Ioneer's $72 Million Equity Raise: A Strategic Lifeline or Dilution Dilemma for Nevada's Rhyolite Ridge?

Australian miner ioneer has secured A$72 million in fresh capital to advance its flagship Nevada lithium-boron project. While the funds de-risk near-term construction, the discounted share placement sparks debate over strategic leverage versus shareholder dilution in a critical minerals race increasingly shaped by U.S. industrial policy.

Feb 2, 2026

Business

From Hurricanes to Sentiment: Wintermute Predicts Crypto Prediction Markets Will Upend Insurance by 2026

A new report from crypto market maker Wintermute Ventures forecasts a seismic shift, arguing that blockchain-based prediction markets will begin displacing traditional insurance by making hyper-specific risks tradable. The firm outlines a future where decentralized infrastructure becomes the new clearing layer for a programmable global economy.

Feb 2, 2026

Business

Geopolitical Tremors Eclipse Fundamentals as Dominant Market Force in 2026

A volatile January has underscored a stark shift for investors: political shocks emanating from Washington now pose a greater threat to portfolios than traditional economic or earnings concerns, reshaping risk calculus across global markets.

Feb 2, 2026

Business

Intellia Therapeutics Sees Analyst Price Target Surge After FDA Lifts Clinical Hold on Key Gene Therapy Trial

Following the FDA's decision to remove the clinical hold on Intellia's Nex-Z hATTR-PN trial, analysts at Baird and H.C. Wainwright have significantly raised their price targets for the CRISPR gene-editing pioneer, citing reduced regulatory risk and a clearer path forward.

Feb 2, 2026

Business

Goldman Sachs Downgrades MoonLake to Sell, Citing Trial Setback and Regulatory Hurdles

Goldman Sachs has downgraded MoonLake Immunotherapeutics (MLTX) to Sell, highlighting the failed VELA-2 trial endpoint and persistent approval risks for its key drug, sonelokimab, despite a competing firm's more bullish outlook.

Feb 2, 2026

World

A Shift in Momentum: IMF Forecasts Africa to Outpace Asia in Economic Growth This Year

The International Monetary Fund projects average growth in sub-Saharan Africa at 4.6% for the year, edging ahead of Asia's 4.1%, signaling a potential turning point driven by demographics but tempered by significant investment challenges.

Feb 2, 2026

Business

Dangote Group Inks Major Gas Supply Pact with NNPC, Aligning with Nigeria's Energy Expansion Drive

Africa's largest conglomerate secures a strategic gas supply agreement with Nigeria's state oil firm, a key move supporting national ambitions to leverage vast gas reserves for industrial growth and investment.

Feb 2, 2026

Business

Skyworks Solutions Shares Slump in Q4 as Value Strategy Underperforms Broader Market

Pzena Investment Management's Focused Value Strategy lagged behind its benchmark in Q4 2025, with semiconductor firm Skyworks Solutions cited as a key detractor. The fund's commentary highlights the challenges for value investing in a market dominated by AI and mega-cap stocks.

Feb 2, 2026

Business

Dollar General's Earnings Surge Fuels Q4 Rally, Defying Broader Market Trends

Amid a quarter dominated by mega-cap tech and AI fervor, Pzena Investment Management's value-focused fund highlighted discount retailer Dollar General as a key performer, driven by strong earnings that propelled its stock.

Feb 2, 2026

Business

Fidelity, Broadcom Reach Settlement in Critical Software Access Dispute

Fidelity Investments and Broadcom have settled a legal dispute that threatened Fidelity's access to business-critical software, averting a potential operational crisis. The agreement, reached just before a key court hearing, ensures continued service for a Fidelity subsidiary.

Feb 2, 2026

Business

Curreen Capital's 'Ugly Duckling' Strategy Delivers 31% Gain, Eyes VF Corp Amid Apparel Giant's Slump

Investment firm Curreen Capital posted strong 2025 results, crediting its focus on undervalued 'ugly duckling' stocks. The fund's latest letter spotlights VF Corporation (VFC), the embattled owner of Vans and The North Face, as a potential turnaround play despite its shares falling over 20% in the past year.

Feb 2, 2026

Business

Curreen Capital's 'Ugly Duckling' Strategy Pays Off, Spotlights Advance Auto Parts

Investment firm Curreen Capital, which targets undervalued 'ugly duckling' companies, reported strong 2025 returns. Its latest investor letter highlights automotive parts retailer Advance Auto Parts (AAP) as a prime example of its contrarian approach, despite the stock's recent volatility and mixed performance.

Feb 2, 2026

Business

Curreen Capital's 'Ugly Duckling' Strategy Delivers Strong 2025 Returns, Spotlights Frontdoor

Investment firm Curreen Capital posted a 30.97% annual return for 2025, crediting its focus on undervalued, well-managed companies. The firm's latest investor letter highlights home service provider Frontdoor (FTDR) as a key holding, despite it not being among the most popular hedge fund picks.

Feb 2, 2026

Business

Vanguard Slashes Fees on Dozens of Funds, Intensifying Price War in Asset Management

The investment giant Vanguard has cut management fees on 53 of its mutual funds and ETFs, a move projected to save investors nearly $250 million in 2026 and marking the latest salvo in an industry-wide race to lower costs for everyday savers.

Feb 2, 2026

Business

Curreen Capital's 'Crazy Cheap' Bet on Fortrea Pays Off as Fund Posts Strong 2025 Gains

Investment firm Curreen Capital, known for targeting undervalued 'ugly duckling' companies, highlighted contract research organization Fortrea Holdings as a prime example of its strategy in its latest investor letter. The firm reported a 30.97% return for 2025.

Feb 2, 2026

Business

FPA Crescent Fund Sheds Microsoft Stake, Citing AI Valuation Concerns and Shifting Portfolio Strategy

First Pacific Advisors' FPA Crescent Fund disclosed it sold its position in tech giant Microsoft in Q4 2025. The value-focused fund explained the move was driven by a search for greater upside in other AI-related investments, despite acknowledging Microsoft's strong fundamentals.

Feb 2, 2026

Business

Why Micron Technology Became Ashva Capital's Crown Jewel: A Bet on Memory's Future

Investment firm Ashva Capital Management reveals Micron Technology as its largest holding in its latest investor letter, detailing a conviction play on the memory chip giant's long-term trajectory amid AI-driven demand and market volatility.

Feb 2, 2026

Business

Banorte's Shifting Price Targets Signal Renewed Market Scrutiny

A revised analyst price target for Grupo Financiero Banorte (BMV:GFNORTE O) is refocusing investor attention on the Mexican banking giant, highlighting how evolving assessments of risk and growth potential can rapidly reshape a stock's narrative.

Feb 2, 2026

Business

BlackRock's Private Markets Ambition Faces Scrutiny Amid Valuation Concerns

As BlackRock expands access to private assets for wealthy clients through a new partnership, a significant markdown in one of its private credit portfolios and a new executive incentive plan are drawing investor attention to the risks and opacity inherent in the booming alternatives space.

Feb 2, 2026

Business

Giverny Capital Trims Position in AMETEK, Citing Valuation Concerns Amid Tech Frenzy

Investment firm Giverny Capital Asset Management reduced its stake in industrial manufacturer AMETEK in Q4 2025, highlighting a disciplined approach to valuation as markets remain captivated by AI narratives. The firm's portfolio underperformed major indices, pressured by its underweight stance in mega-cap technology.

Feb 2, 2026